Chad Messer
Stock Analyst at Lake Street
(0.29)
# 4,528
Out of 5,043 analysts
491
Total ratings
35.4%
Success rate
-3.1%
Average return
Main Sectors:
Stocks Rated by Chad Messer
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CGEN Compugen | Reiterated: Buy | $6 | $2.13 | +181.69% | 5 | Oct 6, 2026 | |
| COYA Coya Therapeutics | Reiterated: Buy | $17 | $4.95 | +243.43% | 15 | Oct 6, 2026 | |
| CNSY Cerenome | Reiterated: Buy | $50 → $31 | $1.93 | +1,506.22% | 7 | Oct 1, 2026 | |
| OSTX OS Therapies | Reiterated: Buy | $13 | $1.62 | +702.47% | 20 | Sep 9, 2026 | |
| GNLX Genelux | Reiterated: Buy | $16 | $2.56 | +525.00% | 6 | Jun 30, 2026 | |
| MNPR Monopar Therapeutics | Reiterated: Buy | $103 | $78.96 | +30.45% | 7 | Jun 30, 2026 | |
| KZIA Kazia Therapeutics | Initiated Coverage: Buy | $32 | $8.93 | +258.34% | 1 | Jun 11, 2026 | |
| IMNM Immunome | Reiterated: Buy | $30 | $19.55 | +53.45% | 9 | Jun 1, 2026 | |
| ONCY Oncolytics Biotech | Reiterated: Buy | $5 | $0.557 | +797.67% | 18 | Jun 1, 2026 | |
| LTRN Lantern Pharma | Reiterated: Buy | $25 | $0.8127 | +2,976.17% | 13 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $75 | $4.11 | +1,724.82% | 6 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $10.48 | - | 1 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $7 | $7.06 | n/a | 18 | Nov 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $3 | $1.23 | n/a | 17 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 | $7.38 | n/a | 7 | Aug 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $49 | $5.97 | n/a | 5 | Aug 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $0.000001 | n/a | 11 | Aug 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $50 | $67.94 | n/a | 2 | Aug 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $48 | $62.91 | n/a | 31 | Aug 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $30 | $7.18 | n/a | 13 | Aug 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $10 | $0.8011 | n/a | 17 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $21 | $1.81 | n/a | 17 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $12 | $85.69 | n/a | 19 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $84 | $45.28 | n/a | 50 | Aug 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $40.10 | n/a | 25 | Aug 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $6 | $0.000001 | n/a | 17 | Jul 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $48 | $22.35 | n/a | 6 | Jul 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $33 → $30 | $59.86 | n/a | 22 | Jun 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $75 → $83 | $1.40 | n/a | 4 | Jun 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $166 | $17.85 | n/a | 50 | May 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $10 | $0.3499 | n/a | 2 | May 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $31.81 | n/a | 21 | May 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $3.52 | n/a | 3 | Nov 8, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 → $27 | $17.59 | n/a | 3 | Apr 12, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $33 | $7.41 | n/a | 10 | Dec 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $7 | $0.000001 | n/a | 5 | May 7, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 → $4 | $11.65 | n/a | 6 | Mar 6, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $17 | $0.9555 | n/a | 1 | Jan 5, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5 | $0.9532 | n/a | 1 | May 22, 2012 |
Compugen
Oct 6, 2026
Reiterated: Buy
Price Target: $6
Current: $2.13
Upside: +181.69%
Coya Therapeutics
Oct 6, 2026
Reiterated: Buy
Price Target: $17
Current: $4.95
Upside: +243.43%
Cerenome
Oct 1, 2026
Reiterated: Buy
Price Target: $50 → $31
Current: $1.93
Upside: +1,506.22%
OS Therapies
Sep 9, 2026
Reiterated: Buy
Price Target: $13
Current: $1.62
Upside: +702.47%
Genelux
Jun 30, 2026
Reiterated: Buy
Price Target: $16
Current: $2.56
Upside: +525.00%
Monopar Therapeutics
Jun 30, 2026
Reiterated: Buy
Price Target: $103
Current: $78.96
Upside: +30.45%
Kazia Therapeutics
Jun 11, 2026
Initiated Coverage: Buy
Price Target: $32
Current: $8.93
Upside: +258.34%
Immunome
Jun 1, 2026
Reiterated: Buy
Price Target: $30
Current: $19.55
Upside: +53.45%
Oncolytics Biotech
Jun 1, 2026
Reiterated: Buy
Price Target: $5
Current: $0.557
Upside: +797.67%
Lantern Pharma
May 18, 2026
Reiterated: Buy
Price Target: $25
Current: $0.8127
Upside: +2,976.17%
May 13, 2026
Reiterated: Buy
Price Target: $75
Current: $4.11
Upside: +1,724.82%
Apr 30, 2026
Reiterated: Buy
Price Target: n/a
Current: $10.48
Upside: -
Nov 1, 2021
Reiterated: Buy
Price Target: $6 → $7
Current: $7.06
Upside: n/a
Aug 17, 2021
Rated: Buy
Price Target: $3
Current: $1.23
Upside: n/a
Aug 13, 2021
Reiterated: Buy
Price Target: $29
Current: $7.38
Upside: n/a
Aug 12, 2021
Reiterated: Buy
Price Target: $49
Current: $5.97
Upside: n/a
Aug 10, 2021
Reiterated: Buy
Price Target: $5
Current: $0.000001
Upside: n/a
Aug 10, 2021
Rated: Buy
Price Target: $50
Current: $67.94
Upside: n/a
Aug 6, 2021
Rated: Buy
Price Target: $48
Current: $62.91
Upside: n/a
Aug 6, 2021
Rated: Buy
Price Target: $30
Current: $7.18
Upside: n/a
Aug 5, 2021
Rated: Buy
Price Target: $10
Current: $0.8011
Upside: n/a
Aug 5, 2021
Rated: Buy
Price Target: $21
Current: $1.81
Upside: n/a
Aug 5, 2021
Rated: Buy
Price Target: $12
Current: $85.69
Upside: n/a
Aug 4, 2021
Rated: Buy
Price Target: $84
Current: $45.28
Upside: n/a
Aug 4, 2021
Rated: Hold
Price Target: n/a
Current: $40.10
Upside: n/a
Jul 29, 2021
Rated: Buy
Price Target: $6
Current: $0.000001
Upside: n/a
Jul 15, 2021
Rated: Buy
Price Target: $48
Current: $22.35
Upside: n/a
Jun 28, 2021
Reiterated: Buy
Price Target: $33 → $30
Current: $59.86
Upside: n/a
Jun 7, 2021
Reiterated: Buy
Price Target: $75 → $83
Current: $1.40
Upside: n/a
May 18, 2021
Reiterated: Buy
Price Target: $166
Current: $17.85
Upside: n/a
May 14, 2021
Rated: Buy
Price Target: $10
Current: $0.3499
Upside: n/a
May 10, 2021
Rated: Hold
Price Target: n/a
Current: $31.81
Upside: n/a
Nov 8, 2019
Rated: Hold
Price Target: n/a
Current: $3.52
Upside: n/a
Apr 12, 2018
Reiterated: Buy
Price Target: $30 → $27
Current: $17.59
Upside: n/a
Dec 9, 2016
Reiterated: Buy
Price Target: $6 → $33
Current: $7.41
Upside: n/a
May 7, 2015
Reiterated: Buy
Price Target: $10 → $7
Current: $0.000001
Upside: n/a
Mar 6, 2015
Reiterated: Buy
Price Target: $7 → $4
Current: $11.65
Upside: n/a
Jan 5, 2015
Initiated Coverage: Buy
Price Target: $17
Current: $0.9555
Upside: n/a
May 22, 2012
Initiated Coverage: Buy
Price Target: $5
Current: $0.9532
Upside: n/a